🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
1,032

Quick answer

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. SP, chloroquine, amodiaquine, primaquine, artesunate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule completed

    1 trial

  2. SR-A + Epratuzumab

    United Therapeutics Europe Ltd

    Acute Lymphoblastic Leukemia (ALL)

    phase 3 small molecule completed

    1 trial

  3. Standard of Care PO (oral) antibiotics

    United Therapeutics Europe Ltd

    Infections

    phase 3 small molecule active

    1 trial

  4. Standard treatment: Control arm

    United Therapeutics Europe Ltd

    Cervical Carcinoma

    phase 3 other active

    1 trial

  5. Sufentanil 30 MCG Sublingual Tablet

    United Therapeutics Europe Ltd

    Traumatic Injury

    phase 3 small molecule completed

    1 trial

  6. Surgery with an external ring fixator

    United Therapeutics Europe Ltd

    Severe Open Fractures of the Tibia (Shin) Bone

    phase 3 other completed

    1 trial

  7. TKI

    United Therapeutics Europe Ltd

    NSCLC

    phase 3 small molecule active

    1 trial

  8. TPOXX

    United Therapeutics Europe Ltd

    Smallpox

    phase 3 small molecule completed

    1 trial

  9. Tadalafil

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  10. Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

    United Therapeutics Europe Ltd

    Critical Illness

    phase 3 other active

    2 trials

  11. Tenofovir gel

    United Therapeutics Europe Ltd

    HIV Prevention

    phase 3 small molecule completed

    1 trial

  12. Teriparatide

    United Therapeutics Europe Ltd

    Stress Fracture

    phase 3 small molecule active

    1 trial

  13. Thalidomide

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  14. The Placebo Nebuliser Solution is a solution dosage form for nebulisation identical to Treprostinil Nebuliser Solution drug product except for the absence of the treprostinil drug substance., Treprostinil

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  15. Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine

    United Therapeutics Europe Ltd

    COVID-19

    phase 3 small molecule terminated

    1 trial

  16. Tobramycin Injection

    United Therapeutics Europe Ltd

    Wound Infection

    phase 3 small molecule active

    1 trial

  17. Tranexamic Acid

    United Therapeutics Europe Ltd

    Spinal Injuries

    phase 3 small molecule active

    1 trial

  18. Treatment group

    United Therapeutics Europe Ltd

    Post Operative Surgical Site Infection

    phase 3 small molecule completed

    1 trial

  19. Treprostinil, The Placebo Nebuliser Solution is a solution dosage form for nebulisation identical to Treprostinil Nebuliser Solution drug product except for the absence of the treprostinil drug substance.

    United Therapeutics Europe Ltd

    Progressive Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  20. Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)

    United Therapeutics Europe Ltd

    Nausea

    phase 3 small molecule active

    1 trial

  21. UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 3 mab active

    4 trials

  22. UI022 or UI023 and co-administration of matching placebo

    United Therapeutics Europe Ltd

    Peripheral Arterial Disease

    phase 3 small molecule completed

    1 trial

  23. UI05MSP015CT

    United Therapeutics Europe Ltd

    Functional Dyspepsia

    phase 3 small molecule completed

    1 trial

  24. UT-15

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  25. UT-15C (treprostinil diolamine)

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 3 small molecule completed

    1 trial

  26. UT-15C SR

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  27. UT-15C SR

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 3 small molecule completed

    3 trials

  28. Venetoclax 400

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  29. Vitamin A

    United Therapeutics Europe Ltd

    Sepsis

    phase 3 other completed

    1 trial

  30. Warfarin

    United Therapeutics Europe Ltd

    Subsegmental Pulmonary Embolism Nos

    phase 3 small molecule active

    1 trial

  31. Wheat Soy Blend (WSB++)

    United Therapeutics Europe Ltd

    Stunting

    phase 3 other completed

    1 trial

  32. Zinc sulphate

    United Therapeutics Europe Ltd

    Diarrhea

    phase 3 other completed

    1 trial

  33. Zinc sulphate 20 mg

    United Therapeutics Europe Ltd

    Bronchiolitis

    phase 3 small molecule completed

    1 trial

  34. Zoledronic acid

    United Therapeutics Europe Ltd

    Osteoporosis

    phase 3 small molecule terminated

    1 trial

  35. abamectin and fenpyroximate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule terminated

    1 trial

  36. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 small molecule active

    1 trial

  37. bLF (Bovine lactoferrin)

    United Therapeutics Europe Ltd

    Neonatal Sepsis

    phase 3 other active

    1 trial

  38. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  39. doxorubicin hydrochloride

    United Therapeutics Europe Ltd

    Stage III Bladder Cancer

    phase 3 small molecule completed

    1 trial

  40. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other completed

    1 trial

  41. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  42. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  43. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  44. low titer whole blood

    United Therapeutics Europe Ltd

    Hemorrhagic Shock

    phase 3 mab completed

    1 trial

  45. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  46. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  47. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

  48. probiotic strain Bb-12

    United Therapeutics Europe Ltd

    Infections, Respiratory

    phase 3 other completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.